CORDIS · 101071784 · HORIZON

DRIMMS Lipid droplets as innate immunity hubs

Coordinator: FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (ES)

Successful defence against invaders is critical for survival of eukaryotic cells. Microbes have developed many strategies to subvert host organisms which, in turn, evolved several innate immune responses to counterattack. As major lipid storage organelles of eukaryotes, lipid droplets (LDs) are an attractive source of nutrients for invaders. Pathogens induce and physically interact with LDs and the current view is that they hijack LDs to draw on substrates for host colonisation. We recently challenged this dogma by demonstrating that LDs are endowed with a regulated protein-mediated antibioti…

EU contribution
€8.8M
Total cost
€8.8M
Period
2023-01-01 → 2028-12-31
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-ERC-SYG
Call
ERC-2022-SYG
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

EU contribution: €8.8M awarded to the consortium. The project runs over approximately 6 years from 2023-01-01 to 2028-12-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-ERC-SYG funding scheme.
What is the EU contribution?
The European Commission contributes €8.8M toward a total project budget of €8.8M.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call ERC-2022-SYG.
Who coordinates the project?
The project is coordinated by FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (ES).
What is the project timeline?
The project runs from 2023-01-01 to 2028-12-31 — approximately 6 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101071784.